The Genetics of Systemic Lupus Erythematosus

Annals of the Academy of Medicine Singapore

Volumn 27, Issue 1, 1998, Pages 42-46

  Fong, K Y ^a   Boey, M L ^a  

^a TAN TOCK SENG HOSPITAL   (Singapore)

Author keywords

Genome scanning; HLA DR2; HLA DR3; Linkage disequilibrium; Susceptibility genes

Indexed keywords

IMMUNOGLOBULIN;

ANIMAL; CLINICAL TRIAL; DISEASE PREDISPOSITION; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC COUNSELING; GENETIC MARKER; GENETICS; GENOME; HUMAN; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; REVIEW; RISK FACTOR; SINGAPORE; SYSTEMIC LUPUS ERYTHEMATOSUS; TWINS;

ANIMALS; CLINICAL TRIALS; DISEASE SUSCEPTIBILITY; DISEASES IN TWINS; FEMALE; GENETIC COUNSELING; GENETIC MARKERS; GENOME, HUMAN; HUMANS; IMMUNOGLOBULINS; LINKAGE DISEQUILIBRIUM; LUPUS ERYTHEMATOSUS, SYSTEMIC; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; RISK FACTORS; SINGAPORE;

EID: 0031627414     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Hahn B H, Tsao B P. Antibodies to DNA. In: Wallace D J, Hahn B H, editors. Dubois Lupus Erythematosus. 4th ed. Philadelphia: Lea and Febiger, 1993:195-201.
2. Kotzin B L Systemic lupus erythematosus. Cell 1996; 85:303-6
3. Cervera R, Khamashta M A, Font J, Sebastian G D, Gil A, Levilla P, et al. Systemic lupus erythematosus. Clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. Medicine (Baltimore) 1993; 72:113-24.
4. Fong K Y, Boey M L, Howe H S, Feng P H Antinuclear antibodies in systemic lupus erythematosus Med J Malaysia 1989; 44 151-5.
5. Lahita R G, Bradlow H L, Kunkel H G, Fishman J. Increased 16 alpha-hydroxylation of estradiolin systemiclupus erythematosus. J Clin Endocrinol Metab 1981;53:174-8.
6. Jungher P, Nahoul K, Pelissier C, Dougados M, Tron F, Nach J F. Low plasma androgens in women with active or quiescent systemic lupus erythematosus. Arthritis Rheum 1982; 25:454-7.
7. Lahita R G, Kunkel H G, Bradlow H L. Increased oxidation of testosterone in systemic lupus erythematosus. Arthritis Rheum 1983; 26:517-21.
8. Walker S E, Allen S H, Hoffman R W, McMurray R W. Prolactin: a stimulator of disease activity in systemic lupus erythematosus. Lupus 1995; 4:3-9.
9. Neidhart M. Elevated serum prolactin or elevated prolactin/cortisol ratio are associated with autoimmune processes in systemic lupus erythematosus and other connective tissue diseases. J Rheumatol 1996; 23:476-81.
10. Besedovsky H O, del Ray A, Klusman I. Cytokines as modulators of the hypothalamus-pituitary-adrenal axis. J Steroid Biochem Mol Biol 1991; 40:613-8.
11. Kraf F E, Hermann M, Leitmann W, Kalden J R. Are retroviruses involved in the pathogenesis of SLE? Evidence demonstrated by molecular analysis of nucleic acids from SLE patients' plasma. Rheumatol Int 1989; 9:115-21
12. Love L A. New environmental agents associated with lupus-like disorders. Lupus 1994; 3 467-71.
13. Reveille J D. Molecular genetics of systemic lupus erythematosus and Sjogren's syndrome. Curr Opin Rheumatol 1990, 5:733-9.
14. Falconer D S. The inheritance of liability of certain diseases estimated from the incidence among relatives. Ann Hum Genet 1965; 29:51-76.
15. Arnett F C The genetic basis of lupus erythematosus. In: Wallace D J, Hahn B H, editors. Dubois Lupus Erythematosus. 4th ed. Philadelphia: Lea and Febiger; 1993:13-36.
16. Robbins P D, Evans C H. Prospects for treating autoimmune and inflammatory diseases by gene therapy. Gene Ther 1996; 3:187-9
17. Lander E S, Schork N J. Genetic dissection of complex traits Science 1994; 265:2037-48.
18. Block S R, Winfield J B, Lockshin M D, D'angelo W A, Christian C L. Studies of twins with systemic lupus erythematosus: A review of the literature and presentation of 12 additional sets. Am J Med 1975; 59:533-52.
19. Block S R, Lockshin M D, Winfield J B, Weksler M E, Imamura M, Winchester R J, et al Immunologic observations on 9 sets of twins either concordant or discordant for SLE. Arthritis Rheum 1976; 19:545-54
20. Winchester R J, Lahita R G. Genetic susceptibility to systemic lupus. In: Lahita R G, editor Systemic Lupus Erythematosus. New York John Wiley and Sons, 1987:81-118.
21. Lawrence J S, Martins C L, Drake G L. A family survey of lupus erythematosus. I. Heritability. J Rheumatol 1987; 14:913-21.
22. Emery A E H, Lawrence J S. Genetics of ankylosing spondylitis. J Med Genet 1967; 4:239-44.
23. Lawrence J S, Gelsthorpe K, Morell G. Heberden's nodes and HLA markers in generalised osteoarthritis. J Rheumatol 1983; 10:32-3.
24. Kaplan D. The onset of disease in twins and siblings with systemic lupus erythematosus. J Rheumatol 1984; 11:648-52.
25. Citera G, Wilson W A. Ethnic and geographic perspective in SLE. Lupus 1993; 2:351-3
26. Ottman R. Gene environment interaction: definitions and study design Prev Med 1996; 25:764-70.
27. Arnett F C, Shulman L E Studies in familial systemic lupus erythematosus. Medicine (Baltimore) 1976; 55:313-22
28. Alarcon-Riquelme M. An approach to the study of the genetics of SLE. In: Feng P H, editor. Proceedings of the 19th ILAR Congress of Rheumatology; 1997Jun8-13;Singapore. Singapore: Communication Consultants, 1997:179-80
29. Morel L, Yu Y, Blenman K R, Caldwell R A, Wakeland E K, Production of congenic mouse strains carrying genomic intervals containing SLE-susceptibility genes derived from the SLE-prone NZM2410 strain. Mamm Genome 1996; 7:335-9.
30. Drake C G, Babcock S K, Palmer E, Kotzin B L Genetic analysis of the NZB contribution to lupus-like autoimmune disease in (NZB × NZW) F1 mice. Proc Natl Acad Sci USA 1994; 91:4062-6.
31. Kono D H, Burhngame R W, Owens D, Kuramochi A, Banderas R S, Balomenos D, et al. Lupus susceptibility loci in New Zealand mice Proc Natl Acad Sci USA 1994; 91:10168-72.
32. Mohan C, Alas E, Morel L, Yang P, Wakeland E K. Genetic dissection of SLE pathogenesis: Sle 1 on murine chromosome 1 leads to loss of tolerance to H2A/H2B/DNA subnucleosomes [abstract]. Arthritis Rheum 1996;39:S216.
33. Tsao B P, Cantor R M, Kalunian K C, Chen C J, Badsha H, Singh R, et al Evidence for linkage of a candidate chromosome 1 region to human systemic lupus erythematosus. J Clin Invest 1997; 99:725-31.
34. Wu J, Zhou T, Zhang J, He J, Cause W C, Mountz J D. Correction of accelerated autoimmune disease by early replacement of the mutated lpr gene with the normal Fas apoptosis gene in the T cells of transgenic MRL-lpr/lpr mice Proc Natl Acad Sci USA 1994; 91:2344-8.
35. Ohsako S, Hara M, Harigai M, Fukasawa C, Kashiwazaki S. Expression and function of Fas antigen and bcl-2 in human systemic lupus erythematosus lymphocytes. Clin Immunol Immunopathol 1994; 73:109-14.
36. Mysler E, Bini P, Drappa J, Ramos P, Friedman S M, Krammer P H, et al. The apoptosis/Fas protein in human systemic lupus erythematosus. J Clin Invest 1994; 93:1029-34.
37. Olsen M L, Goldstein R, Arnett F C, Duvic M, Pollack M, Reveille J D. C4A gene deletion and HLA associations in black Americans with systemic lupus erythematosus Immunogenetics 1989; 30:27-33.
38. Yamada H, Walanabe A, Mimori A, Nakano K, Takeuchi F, Matsuka K, et al. Lack of gene deletion for complement C4A deficiency in Japanese patients with systemic lupus erythematosus. J Rheumatol 1990; 17:1054-7.
39. Agnello V. Lupusdisease associated with hereditary and acquired deficiencies of complement Semin Immunopathol 1986; 9:161-78.
40. Stern R, Fu S M, Fotino M. Hereditary C2 deficiency. Association with skin lesions resembling the discoid lesion of systemic lupus erythematosus. Arthritis Rheum 1976; 19:517-22.
41. Svejgaard A, Ryder L P. HLA and disease associations: Detecting the strongest associations. Tissue Antigens 1994; 43:18-27.
42. Woodrow J C. Immunogenetics of systemic lupus erythematosus. J Rheumatol 1988; 15:197-9.
43. Mehra N K, Pande I, Taneja V, Uppal S S, Saxena S P, Kumar A, et al. Major histocompatibility complex genes and susceptibility to systemic lupus erythematosus in northern India. Lupus 1993; 2:313-4.
44. Bettinotti M P, Hartung K, Deicher H, Messa G, Kelelr E, Weiss E H, et al. Polymorphism of the tumor necrosis factor β gene in SLE. TNFB-MAC haplotype Immunogenetics 1993; 37:449-54.
45. Fong K Y, Howe H S, Tin S K, Boey M L, Feng P H. Polymorphisms of the regulatory region of tumour necrosis factor alpha gene in patients with systemic lupus erythematosus. Ann Acad Med Singapore 1996; 25:90-3.
46. Hahn B H. MHC and non-MHC genes in lupus. In: Feng P H, editor. Proceedings of the 19th ILAR Congress of Rheumatology; 1997 June 8-13; Singapore. Singapore: Communication Consultants, 1997:90-2.
47. Amett F C, Goldstein R, Duvic N. Major histocompatibility complex genes in systemic lupus erythematosus, Sjogren's syndrome and polymyositis. Am J Med 1988; 85:38-41.
48. Davies E J, Donn R P, Hillaby M C, Grennan D M, Oilier W E. Polymorphisms of the TAP2 transporter gene in systemic lupus erythematosus. Ann Rheum Dis 1994; 53:61-3.
49. Hoffman R W, Sharp G C, Irvin W S, Anderson S K, Hewett J E, Pandey J P Association of immunoglobulin Km and Gm allotypes with specific antinuclear antibodies and disease susceptibility among connective tissue disease patients. Arthritis Rheum 1991; 34:453-8.
50. Cornillet P, Gredy P, Pennaforte J L, Meyer O, Kazutchkine M D, Cohen J H. Increased frequency of the long(S) allotype of CR1 (the C3b/C4b receptor, CD35) in patients with systemic lupus erythematosus. Clin Exp Immunol 1992; 89:22-5.
51. Tebib J G, Alcocer-Verela J, Alarcon-Segovia D, Shur P H. Association between a T-cell receptor restriction fragment length polymorphism and systemic lupus erythematosus. J Clin Invest 1990; 86:1961-7.
52. Davis E J, Snowden N, Hillarby M C, Carthy D, Grennan D M,Thomson W, et al. Mannose-binding protein gene polymorphism in systemic lupus erythematosus. Arthritis Kheum 1995; 38:110-4.
53. Linker-Israeli M L, Wallace D J, Prehn J L, Klmenberg J R. A greater variability in the 3' flanking region of the IL-6 gene in patients with systemic lupus erythematosus. Autoimmunity 1996; 23:199-209.
54. Duits A J, Bootsman H, Derksen R H W M, Spronk P E, Kater L, Kallenberg C G M, et al. Skewed distribution of IgG Fc receptor IIa (CD32) polymorphism is associated with renal disease in systemic lupus erythematosus patients. Arthritis Rheum 1995; 39:1832-6.
55. Salmon J E, Millard S, Schachter L. FcgRIIA alleles are heritable risk factors for lupus nephritis in African-Americans. J Clin Invest 1996; 97:1348-54.
56. Blakemore A I F, Tarlow J K, Cork M J, Gordon C, Emery P, Duff G W. Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus. Arthritis Rheum 1994; 37:1380-5.
57. Danis V A, Millington M, Huang Q, Hyland V, Grennan D. Lack of association between an interleukin-1 receptor antagonist gene polymorphism and systemic lupus erythematosus. Dis Markers 1995; 12:135-9.
58. Hochberg M C. Systemic lupus erythematosus Rheum Dis Clin North Am 1990; 16:617-39.
59. Fessel W J. Epidemiology of systemic lupus erythematosus. Rheum Dis Clin North Am 1988; 14:15-23.
60. Lehman T J, McCurdy D K, Bernstein B H, King K K, Hanson V. Systemic lupus erythematosus in the first decade of life. Pediatrics 1989; 83:235-9.
61. Masi A T. Family, twin and genetic studies of SLE In: Bennett P H, Wood P H N, editors. Population Studies of the Rheumatic Diseases. Amsterdam: Excerpta Medica Foundation, 1968:267-70
62. Lockshin M D, Bonfa E, Elkon K, Druzin M L Neonatal lupus risk to newborns of mothers with systemic Lupus erythematosus. Arthritis Rheum 1988:31 697-701.